Quantum Cyber N.V. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
Quantum Cyber N.V. (QUCY) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of -$528.92 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-08-14
- Quantum Cyber N.V. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-06-30 was -$528.92K, a 430.19% decline year-over-year.
- Quantum Cyber N.V. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $176.53K, a 79.38% decline year-over-year.
- Quantum Cyber N.V. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-06-30 was $160.19K.
- Quantum Cyber N.V. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-03-31 was $856.29K.
- Quantum Cyber N.V. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $1.47M.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2026-06-30 | -$528.92K 10-Q · filed 2026-08-14 | -$352.39K derived: sum of 2 quarters · filed 2026-08-14 | |
| 2026-03-31 | $176.53K 10-Q · filed 2026-08-14 | ||
| 2025-12-31 | $1.47M 10-K · filed 2026-03-31 | ||
| 2025-06-30 | $160.19K 10-Q · filed 2026-08-14 | $1.02M derived: sum of 2 quarters · filed 2026-08-14 | |
| 2025-03-31 | $856.29K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |